featured
Risk of Systemic Adverse Events Associated With Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice
Ophthalmology 2018 Oct 04;[EPub Ahead of Print], MH Maloney, SR Schilz, J Herrin, LR Sangaralingham, ND Shah, AJ BarkmeierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.